2-Week Study In People With Nonalcoholic Fatty Liver Disease



Status:Recruiting
Conditions:Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 65
Updated:3/28/2019
Start Date:June 21, 2018
End Date:April 11, 2019
Contact:Pfizer CT.gov Call Center
Email:ClinicalTrials.gov_Inquiries@pfizer.com
Phone:1-800-718-1021

Use our guide to learn which trials are right for you!

A PHASE 1B, RANDOMIZED, DOUBLE-BLIND (SPONSOR-OPEN), PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACODYNAMICS AND PHARMACOKINETICS OF MULTIPLE ORAL DOSES OF PF- 06865571 FOR 2 WEEKS IN ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE

2-week study in people with nonalcoholic fatty liver disease. Study drug at 1 of 2 doses, or
placebo, will be given for 14 days. Blood samples, heart monitoring, vital signs, and imaging
procedures will be performed.


Inclusion Criteria:

- controlled attenuation parameter greater than or equal to 260 dB/m via FibroScan

- liver fat greater than or equal to 6% via MRI

Exclusion Criteria:

- Chronic liver disease

- Type 2 diabetes requiring drug treatment

- Unable to undergo MRI

- History of heart attack or stroke
We found this trial at
6
sites
High Point, North Carolina 27265
?
mi
from
High Point, NC
Click here to add this to my saved trials
7940 Floyd Curl Dr.
San Antonio, Texas 78229
210-949-0122
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
1085 N Harbor Blvd
Anaheim, California 92801
(714) 774-7777
Anaheim Clinical Trials, LLC Anaheim Clinical Trials (ACT) is a research center of excellence for...
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
Las Vegas, Nevada 89113
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
New Haven, Connecticut 06511
?
mi
from
New Haven, CT
Click here to add this to my saved trials
South Miami, Florida 33143
?
mi
from
South Miami, FL
Click here to add this to my saved trials